The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients.
OBJECTIVE
Interleukin-6 (IL-6) is a key pro-inflammatory and immune-modulatory cytokine of relevance for cardiovascular (CD) diseases. Cardiovascular risk factors that have been reported include oxidative stress markers [nitric oxide (NO), malondialdehyde (MDA), disulphite (SH)]. We aimed to evaluate the relation between the IL-6 G/C gene polymorphism and oxidative stress markers in polycystic ovary syndrome (PCOS) patients.


METHODS
We studied 85 PCOS patients and 115 healthy controls. PCOS was defined by the Rotterdam PCOS consensus criteria.


RESULTS
The genotype IL-6 distribution did differ between the control group (CC 9.6%, GC 63.4%, GG 27.0%) and the PCOS patients (CC 4.7%, GC 29.4%, GG 65.9%) (p<0.001). The frequency of the polymorphic G allele was also not similar for the group with PCOS as for the control group with 80.6% and 58.7%, respectively (p<0.001). No statistically significant difference was determined for MDA and NO levels in PCOS patients and control group (p>0.05). Only SH levels were found to be high in favor of patient group (p<0.05). No statistically significant difference was determined between IL-6 G/C gene polymorphism and oxidative stress markers in PCOS patients and in the control group.


CONCLUSIONS
Gene polymorphism of IL-6 -174 G>C is a risk factor for PCOS in Turkish patients. IL-6 gene polymorphisms are not related to NO, MDA, and SH levels in PCOS. Our negative results in risks factors of CV disorders can probably be explained by the fact that metabolic parameters and endothelial systems of patients may not yet be affected in this short period of time.
Erdogan
M
M
Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, 35100, Izmir, Turkey. drmerdogan61@yahoo.com
Karadeniz
M
M
Berdeli
A
A
Alper
G
G
Caglayan
O
O
Yilmaz
C
C
D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009569:Nitric Oxide / Q000097:blood; D018384:Oxidative Stress; D011085:Polycystic Ovary Syndrome / Q000235:genetics / Q000276:immunology; D020641:Polymorphism, Single Nucleotide; D013447:Sulfites / Q000097:blood; D014421:Turkey; D055815:Young Adult
D015415:Biomarkers; D015850:Interleukin-6; D013447:Sulfites; D009569:Nitric Oxide; D008315:Malondialdehyde
Diabetologia. 2003 May;46(5):625-33
12739017
J Clin Invest. 1996 Jun 1;97(11):2601-10
8647954
Atherosclerosis. 2000 Sep;152(1):203-8
10996356
Nitric Oxide. 2001 Feb;5(1):62-71
11178938
Anal Biochem. 1968 Oct 24;25(1):192-205
4973948
Clin Hemorheol Microcirc. 2005;33(1):41-6
16037631
Fundam Clin Pharmacol. 2002 Dec;16(6):441-53
12685502
Diabetologia. 1985 Jul;28(7):412-9
3899825
Int J Cardiol. 2005 Sep 1;103(3):266-71
16098388
Circulation. 2002 Oct 22;106(17):2250-6
12390956
Redox Rep. 2005;10(5):265-70
16354415
J Clin Invest. 1995 Jul;96(1):60-8
7542286
Hormones (Athens). 2006 Jul-Sep;5(3):171-8
16950750
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1920-5
16741147
Hypertension. 1993 Feb;21(2):129-35
8428775
Fertil Steril. 2001 Sep;76(3):511-6
11532474
Exp Physiol. 1997 Mar;82(2):291-5
9129943
J Am Soc Nephrol. 2006 Mar;17(3):863-70
16467451
J Clin Endocrinol Metab. 1985 Nov;61(5):946-51
4044782
Fertil Steril. 2004 Jun;81(6):1638-41
15193488
J Clin Endocrinol Metab. 2001 Oct;86(10):4666-73
11600523
Przegl Lek. 2006;63(4):234-8
17080748
J Endocrinol Invest. 2006 Mar;29(3):270-80
16682845
Adv Exp Med Biol. 1994;366:165-9
7771250
Hypertension. 1994 Jun;23(6 Pt 2):1121-31
7515853
Hum Reprod. 2004 Jan;19(1):41-7
14688154
Am J Nephrol. 2004 Sep-Oct;24(5):537-42
15523169
Circulation. 2001 Mar 13;103(10):1410-5
11245645
Circulation. 2002 Aug 6;106(6):653-8
12163423
J Midwifery Womens Health. 2006 Nov-Dec;51(6):415-22
17081931
Metabolism. 2006 Mar;55(3):345-52
16483878
J Clin Endocrinol Metab. 2000 Mar;85(3):1334-9
10720087
Int J Immunogenet. 2005 Dec;32(6):349-53
16313298
J Biol Chem. 1993 Oct 5;268(28):21120-9
7691806
Int J Cardiol. 2004 Nov;97(2):205-12
15458685
J Clin Endocrinol Metab. 2003 Feb;88(2):673-9
12574198
Transplant Proc. 2005 Nov;37(9):3796-8
16386542
Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):434-9
12615693
Toxicol Appl Pharmacol. 2006 Sep 15;215(3):250-9
16643973
Diabetes. 1995 Sep;44(9):1054-8
7657028
J Clin Endocrinol Metab. 2004 May;89(5):2160-5
15126536
Circulation. 2005 Mar 22;111(11):1448-54
15781756
Hypertension. 1995 Aug;26(2):327-31
7635543
Diabetologia. 2000 May;43(5):550-7
10855528
Clin Biochem. 2007 Feb;40(3-4):181-7
17070511
J Clin Endocrinol Metab. 2002 Feb;87(2):742-6
11836314
Thromb Haemost. 2006 May;95(5):802-6
16676071
Hum Reprod. 2000 Apr;15(4):785-9
10739820
Gynecol Obstet Invest. 2002;53(3):157-62
12053100
Tohoku J Exp Med. 2003 Nov;201(3):147-55
14649736
Gynecol Endocrinol. 2001 Jun;15(3):198-201
11447731
N Engl J Med. 1993 Dec 30;329(27):2002-12
7504210
J Clin Endocrinol Metab. 2001 Jun;86(6):2453-5
11397838